Heparin-binding epidermal growth factor (EGF)-like growth factor in pediatric patients with type 1 diabetes mellitus

Growth Factors. 2020 Feb;38(2):120-126. doi: 10.1080/08977194.2020.1841757. Epub 2020 Oct 30.

Abstract

Heparin-binding EGF-like growth factor (HB-EGF) is involved in atherosclerosis progression. We investigated association between plasma HB-EGF levels and lipid, oxidative stress and inflammatory biomarkers in pediatric patients with type 1 diabetes mellitus (T1DM). Levels of HB-EGF, high-sensitive C-reactive protein (hsCRP), prooxidant-antioxidant balance (PAB), total antioxidant status (TAS), oxidized low-density lipoproteins (oxLDL), metabolic control and serum lipid parameters and paraoxonase 1 (PON1) activity were determined in 74 patients and 40 controls. In comparison to controls, patients had significantly higher levels (p < 0.01) of HB-EGF, hsCRP, PAB and oxLDL particles (p < 0.001), but lower levels of TAS and PON1 activity. In T1DM group, HB-EFG levels were positively associated with hsCRP, PAB and oxLDL levels. hsCRP and oxLDL levels were independent predictors of HB-EGF concentration. We demonstrated that oxidative modifications of LDL particles and low-grade inflammation are main determinants of increased plasma HB-EGF levels, which indicates an interactive role of oxidative stress, dyslipidemia and inflammation.

Keywords: HB-EGF; hsCRP; oxLDL; oxidative stress; paraoxonase 1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aryldialkylphosphatase / blood
  • Biomarkers / blood
  • C-Reactive Protein / analysis
  • Child
  • Diabetes Mellitus, Type 1 / blood*
  • Diabetes Mellitus, Type 1 / metabolism
  • Female
  • Heparin-binding EGF-like Growth Factor / blood*
  • Humans
  • Lipoproteins, LDL / blood
  • Male
  • Oxidative Stress

Substances

  • Biomarkers
  • Heparin-binding EGF-like Growth Factor
  • Lipoproteins, LDL
  • C-Reactive Protein
  • Aryldialkylphosphatase
  • PON1 protein, human